World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
47
Citations
10875
World Ranking
4753
National Ranking
1833

Overview

Richard Marlink is affiliated with Rutgers, The State University of New Jersey in the United States. Their research primarily focuses on the field of medicine with a particular emphasis on oncology, epidemiology, and related subfields such as cancer research and hepatology.

The scientist has published extensively on topics including global cancer incidence and screening, hepatitis B and C virus studies, cervical cancer and HPV research, economic and financial impacts of cancer, cancer genomics and diagnostics, as well as HIV/AIDS research and interventions.

Recent publications demonstrate a focus on cancer and infectious diseases in African contexts. Notable papers include:

  • "Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis" (2021, JCO Global Oncology)
  • "Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana" (2020, Medicine)
  • "Advancing oncology drug therapies for sub-Saharan Africa" (2023, PLOS Global Public Health)
  • "Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana" (2020, Pathogens)
  • "Breast cancer patient experiences in the Botswana health system: Is it time for patient navigators?" (2023, Journal of Cancer Policy)

Their collaborative work includes frequent co-authorship with researchers such as Tendani Gaolathe, Peter Vuylsteke, Kirthana Sharma, Refeletswe Lebelonyane, and Reena Antony, reflecting a network of partnerships mainly in infectious disease and cancer research.

Richard Marlink has contributed publications to prominent venues including:

  • JCO Global Oncology
  • Cancer Epidemiology Biomarkers & Prevention
  • Medicine
  • PLOS Global Public Health
  • Frontiers in Microbiology

Best Publications

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes

    Jeffrey S. A. Stringer;Isaac Zulu;Jens Levy;Jens Levy;Elizabeth M. Stringer;Elizabeth M. Stringer

  • Reduced rate of disease development after HIV-2 infection as compared to HIV-1

    Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers

  • Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

    Sheri Weiser;William Wolfe;William Wolfe;David Bangsberg;Ibou Thior

  • Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

    Ibou Thior;Shahin Lockman;Laura M Smeaton;Roger L Shapiro

  • Slower heterosexual spread of HIV-2 than HIV-1.

    P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex

  • Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression

    Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh

  • HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV

    Luis E. Soto-Ramirez;Boris Renjifo;Mary F. McLane;Richard Marlink

  • New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

    P J Kanki;F Barin;S M'Boup;J S Allan

  • A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

    Bluma Brenner;Dan Turner;Maureen Oliveira;Daniela Moisi

  • Natural protection against HIV-1 infection provided by HIV-2.

    K Travers;S Mboup;R Marlink;A Guèye-Nidaye

  • Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

    Siaka Toure;Bertin Kouadio;Catherine Seyler;Catherine Seyler;Moussa Traore

  • Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design?

    V. Novitsky;U. R. Smith;P. Gilbert;M. F. McLane

  • Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis

    Mansour Farahani;Holly Mulinder;Alexander Farahani;Richard Marlink

  • Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.

    Hermann Bussmann;C William Wester;Ndwapi Ndwapi;Nicolas Grundmann

  • Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection

    V. Novitsky;P. Gilbert;T. Peter;M. F. McLane

  • Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

    Phyllis J. Kanki;Souleymane M'Boup;Dominique Ricard;Francis Barin

  • Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

    William R. Wolfe;S. D. Weiser;D. R. Bangsberg;I. Thior

  • Molecular Cloning and Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana

    Vladimir A. Novitsky;Monty A. Montano;Mary F. McLane;Boris Renjifo

  • Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana

    Natalie T. Do;Kelesitse Phiri;Hermann Bussmann;Tendani Gaolathe

  • Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

    C William Wester;Soyeon Kim;Hermann Bussmann;Ava Avalos

  • Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C

    V. Novitsky;H. Cao;N. Rybak;P. Gilbert

  • Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia

    Jeffrey S. A. Stringer;Isaac Zulu;Elizabeth M. Stringer;Albert Mwango

Frequent Co-Authors

Joseph Makhema
Joseph Makhema Harvard University
Myron Essex
Myron Essex Harvard University
Phyllis J. Kanki
Phyllis J. Kanki Harvard University
Souleymane Mboup
Souleymane Mboup Institute of Health Research, Epidemiological Surveillance and Training
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Tak H. Lee
Tak H. Lee King's College London
Mark A. Wainberg
Mark A. Wainberg McGill University
Brian Foley
Brian Foley Los Alamos National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Microbiology, exploring related online degrees can open diverse career avenues. Programs such as online health information management programs cahiim accredited offer a strong foundation in managing healthcare data, a critical skill in medical and research settings.

If you seek quicker entry into the healthcare field, online medical billing and coding certificate fast programs provide streamlined training to help you start working in administrative roles related to healthcare services efficiently.

Beyond microbiology, aspiring professionals can also consider online medical degrees that offer comprehensive training for various medical careers, some of which can be pursued fully or partially online to accommodate flexible learning schedules.

For public health roles, many students explore easy admission online MPH programs that provide a pathway into community health, epidemiology, and health policy fields, complementing a microbiology background with practical public health expertise.

Best Scientists Citing Richard Marlink

Trending Scientists

Recently Published Articles